Skip to content
Screener

Sana Biotechnology SANA Q4 2025 Annual earnings

Reported March 3, 2026 · After market close

EPS-$0.16Miss by $0.03
EPS estimate-$0.13

Next report

Nov 5, 2026 (in 2 months)
EPS estimate-$0.18

Financials

Q4 2025

Income statement

See full
Operating income-$61.2M-20.3%
Net income-$58.8M-19.9%
EPS (diluted)-$0.210.0%

Balance sheet

See full
Cash & equivalents$71.9M-43.7%
Total debt$78.9M-16.3%
Total equity$160.9M-35.8%
Total assets$416.9M-16.8%

Cash flow

See full
Operating cash flow-$32.6M+30.8%
CapEx$873.0K+100%
Free cash flow-$33.5M+29.6%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.08B+198%
Enterprise value$1.09B+230%

Returns & leverage

See full
Return on equity-118.7%+29.1pp
Debt / equity0.5×+0.1×
Current ratio1.9×-1.7×

FAQ

When did Sana Biotechnology report Q4 2025 earnings?
Sana Biotechnology (SANA) reported Q4 2025 earnings on March 3, 2026 after market close.
What were Sana Biotechnology's Q4 2025 revenue and EPS?
Sana Biotechnology reported eps of $-0.16 for Q4 2025.
Did Sana Biotechnology beat estimates in Q4 2025?
EPS missed the consensus estimate of $-0.13 by $0.03.
How did Sana Biotechnology's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 30.4% from $-0.23.
Where can I find Sana Biotechnology's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001193125-26-088203) and the 10-K periodic report (0001193125-26-088215) directly on SEC EDGAR. The filing index links above go to sec.gov.